Psychiatry of Transition in a World in Transition

Status Recruiting

Clinical Trial Summary

This clinical study evaluates risk and protective factor to develop psychopathology in transitional age youth. 300 patients will be recruited at the age of 17 years old and assessed at baseline and 2 years later.

Clinical Trial Description

Emerging adults are a particularly at-risk population in mental health. Transitional age youth have specific needs, not currently covered between child and adolescent mental health services (CAMHS) and adult mental health services (AMHS), mainly because of existing barriers. Movements from one to the other must be planned to achieve optimal patient care.

Our project aims to identify clinical dimensional characteristics contributing to the development of psychopathology during the transition period. Continuities, discontinuities and resilience factors will be explored. The final purpose is to develop a non-stigmatizing approach to reduce rejection from youths in psychopathological suffering and increase social inclusion.

The transversal and trans-diagnostic approach consists of a dimensional evaluation: 300 youth at the age of 17 will be included in a cohort of in-patients, out-patients and control group. Participants will be assessed at baseline and 2 years later. The primary outcome is based on Health of the Nation Outcome Scale for Children and Adolescents, measuring mental health care need, and WHO Quality of Life assessment.

The secondary outcomes include the assessment of dimensions representing risk or protective factors to develop psychopathology and evolution of mental health status during transition age. Baseline evaluation consists in internalizing/externalizing symptoms, impulsivity/compulsivity, emotion regulation, cognitive functioning, social and family functioning, developmental, medical and trauma history. At follow-up, mental health pathways and transition results will be described. ;

Study Design

Related Conditions & MeSH terms

Clinical Trial Details

NCT number	NCT04333797
Study type	Interventional
Source	Queen Fabiola Children's University Hospital
Contact	Véronique Delvenne, MD, PhD
Phone	+32 2 477 21 17
Email	veronique.delvenne@huderf.be
Status	Recruiting
Phase	N/A
Start date	June 2, 2020
Completion date	September 30, 2025

View Details

See also
Status	Clinical Trial	Phase
Completed	`NCT06267534` - Mindfulness-based Mobile Applications Program	N/A
Completed	`NCT04108689` - Internet-based Acceptance and Commitment Training for Elite Ice Hockey Players	N/A
Recruiting	`NCT06012084` - The Development and Evaluation of iCF-PWR for Healthy Siblings of Individuals With Cystic Fibrosis	N/A
Completed	`NCT04085861` - Mental Health in Dancers; an Intervention Study	N/A
Recruiting	`NCT05227352` - Bio-Experiential Spaces for Mental Health in Healthworkers	N/A
Completed	`NCT03663075` - Effect of Group Education and Individual Counselling on Mental Health and Quality of Life in 45-60 Year Old Women	N/A
Completed	`NCT02480907` - Supporting Carers of Children and Adolescents With Eating Disorders in Austria (SUCCEAT)	N/A
Completed	`NCT02157766` - Wisconsin Center for the Neuroscience and Psychophysiology of Meditation	N/A
Completed	`NCT01155687` - Psychosocial Counseling in Afghanistan	N/A
Unknown status	`NCT01177696` - Intervention in Groups of Family Caregivers in Primary Health Care	N/A
Completed	`NCT01037946` - Family to Family: Psychoeducation to Improve Children's Outcomes in HIV+ Families	N/A
Completed	`NCT00700349` - Evaluation of Impacts of Access to Credit and Loan Size for Microcredit Clients in South Africa	N/A
Recruiting	`NCT03885401` - Enhanced Care Planning for Patients With Multiple Chronic Conditions	N/A
Completed	`NCT03118388` - Engaging Homeless Youth in Vocational Training to Meet Their Mental Health Needs	Phase 2
Completed	`NCT05061966` - The Digital Wellbeing Project	N/A
Completed	`NCT04546061` - Project Uplift: Substance Use and Mental Health Treatment for Young Sexual and Gender Minorities	N/A
Completed	`NCT04026308` - Written vs Electronic Safety Planning Study	N/A
Recruiting	`NCT05738109` - Evaluating the Efficacy of a 91-day Self-talk Mental Health Self-care Journal	N/A
Completed	`NCT03901274` - Partnering for Student Wellness	N/A
Not yet recruiting	`NCT05910580` - Improving Alcohol and Substance Use Care Access, Outcome, Equity During the Reproductive Years	N/A

Clinical trials are conducted in a series of steps, called phases - each phase is designed to answer a separate research question.

Phase 1: Researchers test a new drug or treatment in a small group of people for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
Phase 2: The drug or treatment is given to a larger group of people to see if it is effective and to further evaluate its safety.
Phase 3: The drug or treatment is given to large groups of people to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.
Phase 4: Studies are done after the drug or treatment has been marketed to gather information on the drug's effect in various populations and any side effects associated with long-term use.

Psychiatry of Transition in a World in Transition — Transition_psy

Clinical Trial Summary

Clinical Trial Description

Study Design

Related Conditions & MeSH terms